Related Experiment Videos
Non-oncologic indications for ALA-PDT
R-M Szeimies1, M Landthaler, S Karrer
1Department of Dermatology, Regensburg University Hospital, Regensburg, Germany. Rolf-Markus.Szeimies@klinik.uni-regensburg.de
The Journal of Dermatological Treatment
|June 13, 2002
Summary
Topical photodynamic therapy using 5-aminolevulinic acid (ALA-PDT) effectively treats skin tumors and shows promise for inflammatory conditions and viral lesions. ALA-PDT offers a safer alternative to PUVA therapy, with potential applications for conditions like scleroderma and warts.
Area of Science:
- Dermatology
- Photomedicine
- Oncology
Background:
- Topical photodynamic therapy with 5-aminolevulinic acid (ALA-PDT) is established for superficial skin tumors.
- PDT exhibits both cytotoxic and immunomodulatory effects, influencing treatment outcomes.
- Inflammatory skin diseases and viral lesions may benefit from PDT.
Purpose of the Study:
- To explore the efficacy of ALA-PDT beyond its established use in skin tumors.
- To evaluate PDT's potential in treating inflammatory dermatoses and viral skin infections.
- To compare PDT with existing therapies like PUVA, considering safety profiles.
Main Methods:
- Application of topical 5-aminolevulinic acid followed by light activation.
- Administration of varying light doses to elicit specific cellular responses (cytotoxic or immunomodulatory).
- Clinical observation and assessment of treatment outcomes in patients with diverse skin conditions.
Main Results:
- Patients with treatment-resistant localized scleroderma showed significant improvement with repeated ALA-PDT.
- ALA-PDT demonstrated efficacy in recalcitrant warts in a placebo-controlled trial.
- Case reports suggest positive responses in other viral conditions like condylomata acuminata.
Conclusions:
- Topical ALA-PDT is a viable and potentially safer treatment option for various skin conditions, including inflammatory diseases and viral lesions.
- Further controlled clinical trials are necessary to fully establish PDT's effectiveness for inflammatory skin diseases.
- The selective accumulation of protoporphyrin IX in rapidly proliferating cells supports PDT's targeted action.